Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine in CMML
NCT01235117Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Jan 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in chronic myelomonocytic leukemia (CMML), sponsored by University of Leeds. Started Jan 2010; status: completed.
02
Drugs
azacitidine
03
Conditions
chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT01235117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235117.